Theseus Pharmaceuticals, Inc.
THRXDelisted Feb 14, 2024- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001745020
Theseus Pharmaceuticals, Inc. was delisted on Feb 14, 2024; its insiders filed their last Form 4 on Feb 14, 2024; 70 institutions reported holding it in 13F filings for Q4 2023, worth $145.8M in total; no superinvestor held it.
Q4 2023 vs. Q3 2023
How the institutions holding Theseus Pharmaceuticals, Inc. changed between Q3 2023 and Q4 2023.
All holders in Q4 2023All holders in Q3 2023
| Measure | Q3 2023 | Q4 2023 | Change |
|---|---|---|---|
| Holders | 63 | 70 | +7 |
| Shares | 35.3M | 36.0M | +723.8K (+2.1%) |
| Value | $95.5M | $145.8M | +$50.3M (+52.7%) |
New holders (21)
Institutions that held Theseus Pharmaceuticals, Inc. at the end of Q4 2023 but not at the end of Q3 2023.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Tang Capital Management LLC | 3,255,026 | $13.2M | 1.22% |
| BML Capital Management, LLC | 1,108,320 | $4.49M | 3.54% |
| Highbridge Capital Management LLC | 616,860 | $2.50M | 0.13% |
| Beryl Capital Management LLC | 288,887 | $1.17M | 0.64% |
| MMCAP International Inc. SPC | 277,303 | $1.12M | 0.21% |
| ADAR1 Capital Management, LLC | 174,715 | $707.6K | 0.32% |
| Bridgeway Capital Management, LLC | 57,000 | $230.8K | 0.00% |
| Citadel Advisors LLC | 44,098 | $178.6K | 0.00% |
| Virtu Financial LLC | 26,467 | $107.0K | 0.01% |
| Fifth Lane Capital, LP | 25,000 | $101.3K | 0.12% |
| JBF Capital, Inc. | 23,394 | $94.7K | 0.02% |
| Cubist Systematic Strategies, LLC | 18,588 | $75.3K | 0.00% |
| Goldman Sachs Group Inc | 16,982 | $68.8K | 0.00% |
| SG Americas Securities, LLC | 13,212 | $54.0K | 0.00% |
| Susquehanna Portfolio Strategies, LLC | 11,112 | $45.0K | 0.00% |
| AJOVista, LLC | 9,520 | $38.6K | 0.05% |
| The PNC Financial Services Group, Inc. | 917 | $3.71K | 0.00% |
| EverSource Wealth Advisors, LLC | 267 | $1.08K | 0.00% |
| Ronald Blue Trust, Inc. | 278 | $1.00K | 0.00% |
| Russell Investments Group, Ltd. | 63 | $255 | 0.00% |
| Farther Finance Advisors, LLC | 22 | $89 | 0.00% |
Sold out (14)
Institutions that held Theseus Pharmaceuticals, Inc. at the end of Q3 2023 and filed for Q4 2023 without it.
| Institution | Shares, Q3 2023 | Value, Q3 2023 |
|---|---|---|
| Millennium Management LLC | 1,717,862 | $4.62M |
| Price T Rowe Associates Inc | 1,216,500 | $3.27M |
| Nextech Invest AG | 611,310 | $1.64M |
| Rock Springs Capital Management LP | 437,329 | $1.18M |
| Affinity Asset Advisors, LLC | 400,726 | $1.08M |
| Driehaus Capital Management LLC | 232,693 | $625.9K |
| TD Asset Management Inc | 213,896 | $575.4K |
| Boxer Capital, LLC | 150,000 | $403.5K |
| Manufacturers Life Insurance Company, The | 79,751 | $214.5K |
| Gsa Capital Partners LLP | 36,587 | $98.0K |
| Prelude Capital Management, LLC | 27,073 | $72.8K |
| Forefront Analytics, LLC | 17,672 | $47.5K |
| Susquehanna International Group, LLP | 11,112 | $29.9K |
| Red Tortoise LLC | 536 | $1.44K |